Collins Helen Louise — CHIEF MEDICAL OFFICER
Insider trading activity for Collins Helen Louise sourced from SEC EDGAR Form 4 filings.
Overview
- Title: CHIEF MEDICAL OFFICER
- Company: Enliven Therapeutics, Inc.
- Total insider trades: 29
- Total buy volume: $12K
- Total sell volume: $2.7M
- Last trade: Sep 21, 2026
Recent Trades
| Date | Insider | Ticker / Company |
Type | Shares | Value |
| Sep 17, 2026 |
Collins Helen Louise |
ELVN Enliven Therapeutics, Inc. |
OTHER |
5,000 |
N/A |
| Sep 17, 2026 |
Collins Helen Louise |
ELVN Enliven Therapeutics, Inc. |
SELL |
240 |
$12K |
| Sep 17, 2026 |
Collins Helen Louise |
ELVN Enliven Therapeutics, Inc. |
SELL |
1,844 |
$94K |
| Sep 17, 2026 |
Collins Helen Louise |
ELVN Enliven Therapeutics, Inc. |
SELL |
2,916 |
$146K |
| Sep 17, 2026 |
Collins Helen Louise |
ELVN Enliven Therapeutics, Inc. |
OTHER |
5,000 |
$12K |
| Aug 17, 2026 |
Collins Helen Louise |
EELVN EELVN |
SELL |
5,000 |
$293K |
| Aug 17, 2026 |
Collins Helen Louise |
EELVN EELVN |
BUY |
5,000 |
$12K |
| Jun 17, 2026 |
Collins Helen Louise |
ELVN Enliven Therapeutics, Inc. |
OTHER |
5,000 |
N/A |
| Jun 17, 2026 |
Collins Helen Louise |
ELVN Enliven Therapeutics, Inc. |
SELL |
1,133 |
$51K |
| Jun 17, 2026 |
Collins Helen Louise |
ELVN Enliven Therapeutics, Inc. |
SELL |
2,599 |
$114K |
| Jun 17, 2026 |
Collins Helen Louise |
ELVN Enliven Therapeutics, Inc. |
SELL |
1,268 |
$54K |
| Jun 17, 2026 |
Collins Helen Louise |
ELVN Enliven Therapeutics, Inc. |
OTHER |
5,000 |
$12K |
| Jun 4, 2026 |
Collins Helen Louise |
KURA Kura Oncology, Inc. |
OTHER |
35,000 |
N/A |
| May 18, 2026 |
Collins Helen Louise |
ELVN Enliven Therapeutics, Inc. |
OTHER |
5,000 |
N/A |
| May 18, 2026 |
Collins Helen Louise |
ELVN Enliven Therapeutics, Inc. |
SELL |
223 |
$9K |
| May 18, 2026 |
Collins Helen Louise |
ELVN Enliven Therapeutics, Inc. |
SELL |
1,302 |
$52K |
| May 18, 2026 |
Collins Helen Louise |
ELVN Enliven Therapeutics, Inc. |
SELL |
3,475 |
$137K |
| May 18, 2026 |
Collins Helen Louise |
ELVN Enliven Therapeutics, Inc. |
OTHER |
5,000 |
$12K |
| Apr 17, 2026 |
Collins Helen Louise |
ELVN Enliven Therapeutics, Inc. |
OTHER |
5,000 |
N/A |
| Apr 17, 2026 |
Collins Helen Louise |
ELVN Enliven Therapeutics, Inc. |
SELL |
2,441 |
$117K |
← All executives · Full trades feed
